No abstract available
Keywords:
MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Blood Glucose / metabolism*
-
Cardiotonic Agents / pharmacology*
-
Clinical Trials, Phase II as Topic
-
Delayed Diagnosis / adverse effects
-
Delayed Diagnosis / prevention & control
-
Diabetes Mellitus, Type 2* / complications
-
Diabetes Mellitus, Type 2* / diagnosis
-
Diabetes Mellitus, Type 2* / drug therapy
-
Diabetes Mellitus, Type 2* / epidemiology
-
Diabetes Mellitus, Type 2* / metabolism
-
Dipeptidyl-Peptidase IV Inhibitors / pharmacology
-
Global Health
-
Glucagon-Like Peptide 1 / metabolism
-
Glucagon-Like Peptide-1 Receptor
-
Heart Diseases* / epidemiology
-
Heart Diseases* / etiology
-
Heart Diseases* / metabolism
-
Heart Diseases* / prevention & control
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Incretins / metabolism*
-
Models, Animal
-
Receptors, Glucagon / agonists
-
Receptors, Glucagon / metabolism
Substances
-
Blood Glucose
-
Cardiotonic Agents
-
Dipeptidyl-Peptidase IV Inhibitors
-
GLP1R protein, human
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Incretins
-
Receptors, Glucagon
-
Glucagon-Like Peptide 1